<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">neuroblastoma-cell-lines-treated-with-dac-2-deoxy</item><item key="factor_count">2</item><item key="sample_count">16</item><item key="tags"><item>cell</item><item>neuroblastoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-31229</item><item key="id">4194</item><item key="name">Neuroblastoma cell lines treated with DAC (2'-deoxy-5-azacytidine), a DNA-methylation inhibitor</item></item><item><item key="slug">nicotinic-acetylcholine-receptors-and-egf-induce-c</item><item key="factor_count">2</item><item key="sample_count">4</item><item key="tags"><item>adenocarcinoma</item><item>cancer</item><item>cell</item><item>central</item><item>cytokine</item><item>line</item><item>lung</item><item>lung adenocarcinoma</item><item>lung cancer</item><item>nsclc</item><item>protein</item><item>stem cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-44617</item><item key="id">2229</item><item key="name">Nicotinic acetylcholine receptors and EGF induce c-Kit ligand/Stem Cell Factor (SCF) in a &#946;-arrestin-1 and E2F1 dependent manner in NSCLC</item></item><item><item key="slug">nod2-and-desease-associated-variant-nod2-l1007fsin</item><item key="factor_count">2</item><item key="sample_count">27</item><item key="tags"><item>asthma</item><item>atopic eczema</item><item>cell</item><item>crohn disease</item><item>disease</item><item>genome</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-22611</item><item key="id">3725</item><item key="name">NOD2 and desease associated variant NOD2-L1007fsinsC dependent genomewide transcriptional regulation in stable Flp-In HEK cells</item></item><item><item key="slug">notch3-is-a-master-regulator-of-motility-in-neurob</item><item key="factor_count">1</item><item key="sample_count">17</item><item key="tags"><item>cell</item><item>nervous system</item><item>neuroblastoma</item><item>notch</item><item>peripheral</item><item>sympathetic nervous system</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-16477</item><item key="id">2328</item><item key="name">NOTCH3 is a master-regulator of motility in neuroblastoma and is essential for cell survival</item></item><item><item key="slug">notch3-knockdown-in-non-transformed-human-esophage</item><item key="factor_count">2</item><item key="sample_count">12</item><item key="tags"><item>cancer</item><item>carcinoma</item><item>cell</item><item>disease</item><item>finger</item><item>notch</item><item>squamous</item><item>squamous cell</item><item>squamous cell carcinoma</item><item>stem cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-27424</item><item key="id">3972</item><item key="name">NOTCH3 knockdown in non-transformed human esophageal cells</item></item><item><item key="slug">notch-is-active-in-langerhans-cell-histiocytosis-a</item><item key="factor_count">3</item><item key="sample_count">17</item><item key="tags"><item>cell</item><item>dendritic</item><item>disease</item><item>histiocytosis</item><item>langerhans cell</item><item>peripheral</item><item>skin</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-35340</item><item key="id">4395</item><item key="name">Notch is active in Langerhans Cell Histiocytosis and confers pathognomonic features on dendritic cells.</item></item><item><item key="slug">notch-pathway-activation-targets-aml-cell-homeosta</item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>cell</item><item>genome</item><item>line</item><item>notch</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-42259</item><item key="id">2578</item><item key="name">Notch Pathway Activation Targets AML Cell Homeostasis and Differentiation: THP1 cell line</item></item><item><item key="slug">novel-immunotherapy-induced-tertiary-lymphoid-aggr</item><item key="factor_count">2</item><item key="sample_count">20</item><item key="tags"><item>adenocarcinoma</item><item>arm</item><item>cancer</item><item>cell</item><item>chemokine</item><item>ductal adenocarcinoma</item><item>melanoma</item><item>pancreatic ductal adenocarcinoma</item><item>pancreatic tumor</item><item>peripheral</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-52171</item><item key="id">4707</item><item key="name">Novel Immunotherapy-Induced Tertiary Lymphoid Aggregates Accumulate as Intratumoral Nodal Structures of Immune Regulation in Pancreatic Cancer</item></item><item><item key="slug">novel-mutations-target-distinct-subgroups-of-medul</item><item key="factor_count">5</item><item key="sample_count">76</item><item key="tags"><item>brain</item><item>cell</item><item>chromatin</item><item>disease</item><item>lip</item><item>medulloblastoma</item><item>pediatric medulloblastoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-37418</item><item key="id">4469</item><item key="name">Novel mutations target distinct subgroups of medulloblastoma.</item></item><item><item key="slug">novel-properties-of-side-population-cells-in-soft</item><item key="factor_count">1</item><item key="sample_count">8</item><item key="tags"><item>cancer</item><item>cell</item><item>genome</item><item>notch</item><item>sarcoma</item><item>scid</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-24199</item><item key="id">3812</item><item key="name">Novel Properties of Side Population cells in Soft-tissue Sarcoma, and How They May Be Targeted to Develop Potential Therapies</item></item></data></biogps>
